EGFR and glioblastoma: In this study, we performed a comprehensive search of the PubMed, Web of Science, and Scopus databases to identify and analyze relevant clinical trials to evaluate whether EGFR amplification or the EGFRvIII mutation could serve as independent prognostic predictors for GBM.